Fabio Petrocca, MD

I am a physician-scientist with combined training in cancer biology and clinical medicine. My research focuses on the development of immune effector cell therapies for cancer. I also maintain an active clinic for patients with benign or malignant hematologic conditions. I joined BMC in 2021 as founding Director of the Cellular Therapy Program, whose core mission is to enable equitable patient access to innovative and powerful cancer cell therapies such as CART.

Overall, I have 15+ years of hematology/oncology experience. I completed my MD and oncology training in Italy and then did a fellowship in cancer biology at Harvard. I was on the Harvard faculty for 2 years prior to joining BUSM sponsored by a NIH grant. For 4 years, I worked in industry as Medical Director of investigational CAR T cell therapies for various hematologic malignancies, including ide-cel approved for multiple myeloma in 2021. I am currently a full-time faculty at BUSM and an Attending Physician at BMC.

• Residency

  Oncology, University of Ferrara, Italy

• Fellowship

  Research Fellowship, Program in Cellular and Molecular Medicine, Harvard Medical School, Boston, MA

• Board Certifications

  Oncology (Italy)

• Special Interests

  Hematologic malignancies

• Languages

  Italian

• Location

  830 Harrison Ave
  Moakley 3
  Boston, MA 02118

• Pronouns

  He/Him